Lucasbio
Clinical trials sponsored by Lucasbio, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Donor t cells aim to fight severe COVID-19 Results expected Oct 2026 (estimated)
- Immune cells engineered to hunt viruses show promise for transplant kids Results expected May 2027 (estimated)
- Donor cells take on Drug-Resistant viruses in new trial Results expected Jun 2027 (estimated)
- Personalized immune cells take aim at Drug-Resistant eye virus Results expected Aug 2027 (estimated)
-
Boosting the immune system after transplant: could 'Killer' cells prevent relapse?
Disease control CompletedThis study tests whether giving patients their own specially grown immune cells (called cytokine-induced killer cells) shortly after a stem cell transplant is safe. The trial enrolls adults with lymphoma who are receiving a transplant of their own stem cells. Researchers will mon…
Sponsor: LucasBio • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Personalized immune cell therapy aims to clear stubborn COVID-19 infections
Disease control CompletedThis study tests a treatment called LB-DTK-COV19, made from a patient's own immune cells, for people who have had COVID-19 symptoms or a positive test for more than 21 days. Participants receive two infusions of their personalized T cells, two weeks apart, and are followed for si…
Sponsor: LucasBio • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC